# OR1B1

## Overview
The OR1B1 gene encodes the protein olfactory receptor family 1 subfamily B member 1, which is a member of the G-protein-coupled receptor (GPCR) family. This protein is primarily involved in the olfactory system, where it functions as a receptor in the olfactory epithelium, playing a critical role in the detection and transduction of odorant signals into neuronal responses (Gupta2012Sequencing). The OR1B1 protein is characterized by a 7-transmembrane domain structure, typical of GPCRs, which facilitates its interaction with G-proteins and subsequent activation of intracellular signaling pathways. These pathways are essential for the perception of smell and involve molecules such as cyclic AMP (cAMP) and calcium ions (Gupta2012Sequencing). Beyond its role in olfaction, mutations in OR1B1 have been associated with various cancers, including colorectal and breast cancer, indicating its potential involvement in broader physiological and pathological processes (TrasierrasFresco2022DNA; Alquati2021Discovering). Despite its significance, the heritability of OR1B1 expression appears limited, suggesting environmental factors may play a more substantial role in its regulation (Kanchibhotla2023Heritability).

## Function
OR1B1 is an olfactory receptor gene that encodes a protein involved in the detection of odorant molecules. This protein is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in olfactory transduction, the process by which odorant signals are converted into neuronal responses. In healthy human cells, OR1B1 functions as a receptor in the olfactory epithelium, where it binds specific odorants, initiating a signal transduction pathway that results in the perception of smell (Gupta2012Sequencing).

The OR1B1 protein is characterized by a 7-transmembrane domain structure typical of GPCRs, which allows it to interact with G-proteins upon binding to odorant molecules. This interaction triggers intracellular signaling pathways, including those involving cyclic AMP (cAMP) and calcium ions, which are essential for the transmission of olfactory signals to the brain (Gupta2012Sequencing).

Mutations in OR1B1, such as non-sense mutations leading to truncation of the receptor, can affect its function and have been associated with altered metabolic processes, including the metabolism of serum cholinesterase (Gupta2012Sequencing). This highlights the importance of OR1B1 in both olfactory function and broader physiological processes.

## Clinical Significance
Mutations in the OR1B1 gene have been implicated in various neoplasms, including colorectal cancer (CRC) and adenomas. These mutations are considered early driver alterations in CRC, suggesting their potential significance in the early stages of colorectal tumorigenesis (Alquati2021Discovering). The OR1B1 gene is also associated with adenoma evolution within the GPCR signaling pathway, highlighting its role in cancer progression (Angius2021A).

In breast cancer, OR1B1 is identified as a hypomethylated gene, which may serve as a prognostic indicator or therapeutic target. However, the specific clinical significance of OR1B1 mutations in breast cancer remains to be fully understood (TrasierrasFresco2022DNA).

Research into the heritability of gene expression suggests that OR1B1 does not exhibit significant heritability, indicating that environmental factors may influence its expression. This finding suggests that OR1B1's role in disease may be more environmentally driven rather than genetically predisposed (Kanchibhotla2023Heritability).

Overall, while OR1B1 mutations are linked to certain cancers, the full clinical implications of these mutations require further investigation to understand their potential impact on disease development and progression.


## References


[1. (Gupta2012Sequencing) Ravi Gupta, Aakrosh Ratan, Changanamkandath Rajesh, Rong Chen, Hie Lim Kim, Richard Burhans, Webb Miller, Sam Santhosh, Ramana V Davuluri, Atul J Butte, Stephan C Schuster, Somasekar Seshagiri, and George Thomas. Sequencing and analysis of a south asian-indian personal genome. BMC Genomics, August 2012. URL: http://dx.doi.org/10.1186/1471-2164-13-440, doi:10.1186/1471-2164-13-440. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-13-440)

[2. (Angius2021A) Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Ciriaco Carru, Alberto Porcu, Paolo Cossu-Rocca, and Maria Rosaria De Miglio. A portrait of intratumoral genomic and transcriptomic heterogeneity at single-cell level in colorectal cancer. Medicina, 57(11):1257, November 2021. URL: http://dx.doi.org/10.3390/medicina57111257, doi:10.3390/medicina57111257. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/medicina57111257)

[3. (Alquati2021Discovering) Chiara Alquati, Anna Prossomariti, Giulia Piazzi, Francesco Buttitta, Franco Bazzoli, Luigi Laghi, and Luigi Ricciardiello. Discovering the mutational profile of early colorectal lesions: a translational impact. Cancers, 13(9):2081, April 2021. URL: http://dx.doi.org/10.3390/cancers13092081, doi:10.3390/cancers13092081. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13092081)

4. (TrasierrasFresco2022DNA) DNA Methylation Signatures in Breast Cancer: A Systematic Review and Meta-Analysis. This article has 0 citations.

5. (Kanchibhotla2023Heritability) Heritability of Gene Expression measured from Peripheral Blood in Older Adults. This article has 0 citations.